| abstract |
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular Duken's muscular dystrophy (DMD). In some embodiments, the method according to the invention comprises administering an effective amount of a recombinant follistatin protein to an individual suffering from or susceptible to DMD such that at least one symptom or characteristic of DMD is reduced in intensity, severity, or frequency, or delayed onset. Includes. |